Erojavess^® (vernakalant hydrochloride) is for the rapid conversion of recent onset atrial fibriallation (“AF”) to sinus rhythm in adults, for non-surgery patients with AF of seven days or less and for use in post-cardiac surgery patients with AF of three days or less. Brinavess is NOT recommended for conversion of atrial flutter (AFL) to sinus rhythm.